(Q34834695)

4 August 2017

1 reference

title

Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults (English)

1 reference

acute respiratory distress syndrome

4 August 2017

0 references

1 reference

1 reference

Robert MacLaren

1

1 reference

4 August 2017

Rose Jung

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

22

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

1140-1156

1 reference

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Epidemiology of sepsis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

The acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Infections and the inflammatory response in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

The continuing story of corticosteroids in the treatment of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Corticosteroids for septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Corticosteroid therapy in severe illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Corticosteroids and vascular tone: mapping the messenger maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Endothelial and vascular smooth muscle function in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Role of the cytokines in the neuroendocrine-immune system axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic-pituitary-adrenal axis in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Cytokines and the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions*

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Role of NFkappaB in the mortality of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Glucocorticoid resistance in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Syndromes of glucocorticoid resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Relationship of plasma leptin to plasma cytokines and human survivalin sepsis and septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Cytokine balance in the lungs of patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Adrenal insufficiency in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Hormones in the critically ill patient: to intervene or not to intervene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Cortisol response to corticotropin and survival in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Prediction of outcome in intensive care patients using endocrine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Steroid controversy in sepsis and septic shock: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Effect of corticosteroids on nuclear factor-kappaB activation and hemodynamics in late septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Adrenal failure in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose Dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Role of glucocorticoid hormones in arginine vasopressin gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.13.1140.33519

10.1592/PHCO.22.13.1140.33519

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference